Certara Launches Quantitative Systems Pharmacology Consortium on Immuno-oncology

Article

Applied Clinical Trials

Certara announced the launch of its Quantitative Systems Pharmacology (QSP) Immuno-oncology Simulator Consortium. This new QSP brings together biopharmaceutical companies to create a simulator that can model clinical populations of cancer patients in order to improve the development of immuno-oncology therapies.

Read the full release here

Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Related Content
© 2024 MJH Life Sciences

All rights reserved.